Airsculpt Technologies, Inc. (AIRS) fundamentals score
AirSculpt is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin, while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results.
Services-Offices & Clinics of Doctors of Medicine · Healthcare · Listed on NASDAQ
Overall: 4.0 out of 10, Weak long-term fundamentals
- Growth: 4.1/10
- Profitability: 2.0/10
- Financial health: 2.6/10
- Earnings quality: 8.2/10
- Valuation: 4.8/10
Scores are calculated from Airsculpt Technologies, Inc.’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10